Comprehensive biologics operations including research, development, and commercialization activities. This segment focuses on innovative approaches and solutions within the biologics field, leveraging advanced technologies and expertise to address unmet medical needs and improve patient outcomes.

Integrated development and manufacturing services for small molecule drug substances and their intermediates.

Develops technologies and platforms for cell and gene therapies, including contract development and manufacturing services.

Offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers.